1. Toxic Effects on the Host
The toxicity of antimicrobial agents is due to the similarity of their targets with host cellular structures or the specific blood supply of organs. The risk of developing complications depends on the properties of the drug itself, dosage, route of administration, and the patient's condition. Toxicity most frequently manifests during prolonged administration due to cumulative effects. Special risk groups include children, pregnant women, and patients with liver and kidney pathologies.
Main Types of Organ Toxicity:
- Neurotoxicity and ototoxicity: The use of glycopeptides and aminoglycosides can lead to vestibulocochlear nerve damage, potentially resulting in permanent deafness.
- Nephrotoxicity: Renal damage is caused by polyenes, polypeptides, aminoglycosides, macrolides, glycopeptides, and sulfonamides.
- General systemic toxicity: Specific to antifungal agents (polyenes, imidazoles).
- Hematotoxicity: Bone marrow suppression is characteristic of tetracyclines and sulfonamides. Chloramphenicol is notable for containing a nitrobenzene group, which acts as a direct bone marrow suppressor.
Teratogenic and Embryotoxic Effects: Drugs can severely interfere with the development of the fetus and children. Aminoglycosides and tetracyclines disrupt osteogenesis and chondrogenesis (bone and cartilage development). Tetracyclines also cause permanent brown discoloration of tooth enamel due to impaired tooth formation. Quinolones specifically target developing cartilage and connective tissue.
Gray Baby Syndrome: This is a specific toxicity seen in neonates caused by chloramphenicol. Newborns lack fully developed liver enzymes (specifically a deficiency in glucuronyl transferase). Consequently, the drug is not metabolized into glucuronides and accumulates to toxic concentrations. The clinical picture includes ashen-gray skin discoloration, hepatomegaly, vomiting, cardiovascular instability, and profound lethargy. Prevention of any toxic complications requires strict avoidance of contraindicated agents and careful monitoring of hepatic and renal function.
2. Dysbiosis and Negative Impact on the Immune System
Dysbiosis is a direct consequence of the eradication of normal symbiotic microflora. It most commonly occurs when broad-spectrum agents are prescribed.
The pathogenesis of dysbiosis leads to gastrointestinal dysfunction, severe vitamin deficiencies, and secondary infections (superinfections). Resistant opportunistic flora occupy the vacated ecological niche, leading to endogenous infections such as candidiasis or pseudomembranous colitis, caused by Clostridioides difficile (C. difficile). To prevent dysbiosis, it is recommended to use narrow-spectrum agents, combine antibiotics with antifungals (e.g., nystatin), and prescribe vitamin therapy and probiotics.
Negative Impact on the Immune System: Antibiotics can exert immunosuppressive effects, leading to secondary immunodeficiencies and reduced overall immune competence. However, the primary immunological complication is allergic reactions. Sensitization may be caused by the drug itself, its breakdown products, or haptens—complexes formed by the drug with serum proteins. The incidence of allergic reactions reaches up to 10%.
- Mild to moderate forms: Pruritus, rash, urticaria, angioedema.
- Severe forms: Anaphylactic shock (rare) and delayed-type hypersensitivity.
Agents with the highest allergenic potential include beta-lactams (especially penicillins), rifamycins, and sulfonamides. The primary preventive measure is taking a thorough allergy history.
3. Endotoxic Shock, Drug Interactions, and Effects on Microbes
Therapeutic Endotoxic Shock: This is a specific complication occurring during the treatment of infections caused by Gram-negative bacteria. The administration of an effective bactericidal antibiotic causes massive lysis and destruction of bacterial cells, releasing a giant surge of endotoxin into the bloodstream simultaneously. Clinically, this presents as a transient but sharp deterioration in the patient's condition.
Drug Interactions: Chemotherapeutic agents actively affect the pharmacokinetics of other medications, causing potentiation or inactivation. For example, erythromycin stimulates hepatic enzyme production, leading to undesirably accelerated metabolism and clearance of other drugs taken by the patient.
Alteration of Microbial Properties: Adverse effects of chemotherapeutic agents are not limited to destroying the pathogen. Bacteria adapt, leading to the formation of atypical forms:
- Formation of L-forms—bacteria that have completely lost their cell wall.
- Emergence of persister forms and alteration of initial biological properties.
The clinical significance of these transformations is immense: the atypical behavior of the pathogen severely complicates laboratory diagnostics. Furthermore, the evolutionary selection of microbial responses can lead to antibiotic dependence (rare) and antibiotic resistance (very common).